Breast cancer is one of the most hazardous diseases at a later age for women. This article consists of a systematic survey on causes of the disease, the role of BRCA1 gene mutation in BC, and standard operating procedures used to treat breast cancer depending on the size of the tumor, location of cancer, and type of tumor. These include tamoxifen tablets, advance radiation therapy, trastuzumab medication, chemotherapy, hormone replacement therapy. Their success rates are evaluated, and neoadjuvant therapy is used to reduce the intensity of the disease before going for advanced BC treatment. Many other assessments are performed like risk detection based on age, sex, gene, family history, tumor suppression detection, muti variant COX propositional analysis, and over expression. This survey overviews BC disease, treatments available, and their success rates.